{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:10:14Z","timestamp":1793088614224,"version":"4.5.0"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inflammatory bowel disease (IBD) is a pathological condition that first involves the gastrointestinal wall but can also trigger a systemic inflammatory state and thus extraintestinal manifestations. Systemic inflammation is probably secondary to the passage of bacterial products into the bloodstream because of altered intestinal permeability and the consequent release of proinflammatory mediators. Inflammation, through several diverse pathophysiological pathways, determines both a procoagulative state and systemic endothelial dysfunction, which are both deemed to be responsible for venous and arterial thromboembolic adverse events.<\/jats:p>\n               <jats:p>The management of systemic thrombotic complications is particularly challenging in this category of patients, who also present a high bleeding risk; what is more, both bleeding and thrombotic risks peak during the active phases of the disease. The literature suggests that treating physicians have been, so far, more heavily influenced by concerns about bleeding than by the thrombotic risk. Despite the absence of data provided by large cohorts or randomized studies, the high risk of arterial and venous atherothrombosis in patients with IBD seems unquestionable. Moreover, several reports suggest that when arterial thromboembolism involves the coronary vessels, causing acute coronary syndromes, ischemic complications from antithrombotic drug undertreatment are frequent and severe. This review aims to shed light on the tricky balance between the ischemic and hemorrhagic risks of patients with IBD and to highlight how difficult it is for clinicians to define a tailored therapy based on a case-by-case, careful, and unprejudiced clinical evaluation.<\/jats:p>","DOI":"10.1093\/ibd\/izaa160","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T13:24:09Z","timestamp":1593264249000},"page":"725-731","source":"Crossref","is-referenced-by-count":12,"title":["Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk"],"prefix":"10.1093","volume":"27","author":[{"given":"Martino","family":"Pepe","sequence":"first","affiliation":[{"name":"Cardiovascular Diseases Section, Cardiothoracic Department, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Carulli","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Section, Cardiothoracic Department, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Forleo","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Section, Cardiothoracic Department, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8373-8486","authenticated-orcid":false,"given":"Marco","family":"Moscarelli","sequence":"additional","affiliation":[{"name":"Cardiothoracic and Vascular Department, Maria Cecilia Hospital GVM Care and Research , Cotignola (RA) , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"Di Cillo","sequence":"additional","affiliation":[{"name":"Chest Pain Unit, Cardiology Emergency, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Santo","family":"Bortone","sequence":"additional","affiliation":[{"name":"Division of Heart Surgery, Department of Emergency and Organ Transplantation, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma Luisa","family":"Nestola","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Section, Cardiothoracic Department, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"additional","affiliation":[{"name":"Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome , Latina , Italy"},{"name":"Mediterranea Cardiocentro , Napoli , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Giordano","sequence":"additional","affiliation":[{"name":"Invasive Cardiology Unit, Pineta Grande Hospital , Castel Volturno, Caserta , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Favale","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Section, Cardiothoracic Department, University of Bari , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"2022092518580893400_CIT0001","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun Rev."},{"key":"2022092518580893400_CIT0002","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn\u2019s disease","volume":"13","author":"Laass","year":"2014","journal-title":"Autoimmun Rev."},{"key":"2022092518580893400_CIT0003","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management","volume":"42","author":"Larsen","year":"2010","journal-title":"Ann Med."},{"key":"2022092518580893400_CIT0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcmg.2010.09.019","article-title":"Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus","volume":"4","author":"Ishimori","year":"2011","journal-title":"JACC Cardiovasc Imaging."},{"key":"2022092518580893400_CIT0005","first-page":"2372","article-title":"Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities","volume":"27","author":"Bruce","year":"2000","journal-title":"J Rheumatol."},{"key":"2022092518580893400_CIT0006","first-page":"445","article-title":"The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus-related atherosclerosis: a novel target for treatment?","volume":"33","author":"Shovman","year":"2006","journal-title":"J Rheumatol."},{"key":"2022092518580893400_CIT0007","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum-US."},{"key":"2022092518580893400_CIT0008","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation."},{"key":"2022092518580893400_CIT0009","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/CIRCULATIONAHA.106.678334","article-title":"Cardiovascular manifestations of rheumatologic diseases","volume":"116","author":"Roman","year":"2007","journal-title":"Circulation."},{"key":"2022092518580893400_CIT0010","doi-asserted-by":"crossref","first-page":"V67","DOI":"10.1093\/ndt\/gfh1059","article-title":"Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease","volume":"19","author":"Zoccali","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"2022092518580893400_CIT0011","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.tcm.2015.03.010","article-title":"Inflammatory bowel disease and risk of coronary heart disease","volume":"25","author":"Rungoe","year":"2015","journal-title":"Trends Cardiovasc Med."},{"key":"2022092518580893400_CIT0012","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"2022092518580893400_CIT0013","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2036.2005.02657.x","article-title":"Increased carotid intima-media thickness in patients with inflammatory bowel disease","volume":"22","author":"Papa","year":"2005","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092518580893400_CIT0014","first-page":"7","article-title":"Early atherosclerosis in patients with inflammatory bowel disease","volume":"10","author":"Papa","year":"2006","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"2022092518580893400_CIT0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0003319709333869","article-title":"Is inflammatory bowel disease a risk factor for early atherosclerosis?","volume":"61","author":"Dagli","year":"2010","journal-title":"Angiology."},{"key":"2022092518580893400_CIT0016","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.ejcn.1601049","article-title":"Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls","volume":"54","author":"Geerling","year":"2000","journal-title":"Eur J Clin Nutr."},{"key":"2022092518580893400_CIT0017","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ajcn\/71.3.807","article-title":"Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease","volume":"71","author":"Levy","year":"2000","journal-title":"Am J Clin Nutr."},{"key":"2022092518580893400_CIT0018","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1572-0241.2003.07520.x","article-title":"Body composition in patients with inflammatory bowel disease: a population-based study","volume":"98","author":"Jahnsen","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"2022092518580893400_CIT0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejim.2016.10.004","article-title":"Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease","volume":"37","author":"Cappello","year":"2017","journal-title":"Eur J Intern Med."},{"key":"2022092518580893400_CIT0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450116666150202161500","article-title":"Cardiovascular complications in inflammatory bowel disease","volume":"16","author":"Schicho","year":"2015","journal-title":"Curr Drug Targets."},{"key":"2022092518580893400_CIT0021","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/HJH.0b013e3283568abd","article-title":"Arterial stiffness is increased in patients with inflammatory bowel disease","volume":"30","author":"Zanoli","year":"2012","journal-title":"J Hypertens."},{"key":"2022092518580893400_CIT0022","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s10620-012-2148-x","article-title":"Evaluation of early atherosclerosis in patients with inflammatory bowel disease","volume":"57","author":"Kayahan","year":"2012","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun Rev."},{"key":"2022092518580893400_CIT0024","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.19082\/6956","article-title":"Association between carotid intima-media thickness and ulcerative colitis: a systematic review and meta-analysis","volume":"10","author":"Goshayeshi","year":"2018","journal-title":"Electron Physician."},{"key":"2022092518580893400_CIT0025","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet."},{"key":"2022092518580893400_CIT0026","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ajg.2011.53","article-title":"Venous thromboembolism in inflammatory bowel disease: an epidemiological review","volume":"106","author":"Murthy","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"2022092518580893400_CIT0027","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"2022092518580893400_CIT0028","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut."},{"key":"2022092518580893400_CIT0029","doi-asserted-by":"crossref","first-page":"13863","DOI":"10.3748\/wjg.v20.i38.13863","article-title":"Inflammatory bowel disease and thromboembolism","volume":"20","author":"Zezos","year":"2014","journal-title":"World J Gastroenterol."},{"key":"2022092518580893400_CIT0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cgh.2007.09.016","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study","volume":"6","author":"Bernstein","year":"2008","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092518580893400_CIT0031","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.MIB.0000441200.10454.4f","article-title":"Long-term risk of acute coronary syndrome in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population","volume":"20","author":"Tsai","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"2022092518580893400_CIT0032","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ajg.2009.81","article-title":"Risk of arterial thrombotic events in inflammatory bowel disease","volume":"104","author":"Ha","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"2022092518580893400_CIT0033","doi-asserted-by":"crossref","first-page":":e8885","DOI":"10.1097\/MD.0000000000008885","article-title":"Acute myocardial infarction in a young woman with ulcerative colitis: a case report and literature review","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine."},{"key":"2022092518580893400_CIT0034","first-page":"462","article-title":"Late bare-metal stent thrombosis in a patient with Crohn\u2019s disease","volume":"11","author":"Yaz\u0131c\u0131","year":"2011","journal-title":"Anadolu Kardiyol Derg."},{"key":"2022092518580893400_CIT0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/pgmj.2004.018952","article-title":"Active inflammatory bowel disease and coronary artery dissection","volume":"81","author":"Srinivas","year":"2005","journal-title":"Postgrad Med J."},{"key":"2022092518580893400_CIT0036","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10238-018-0522-5","article-title":"Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk","volume":"18","author":"Pepe","year":"2018","journal-title":"Clin Exp Med."},{"key":"2022092518580893400_CIT0037","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9610(02)00879-6","article-title":"Acute surgical emergencies in inflammatory bowel disease","volume":"184","author":"Berg","year":"2002","journal-title":"Am J Surg."},{"key":"2022092518580893400_CIT0038","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.suc.2019.08.007","article-title":"Abdominal emergencies in inflammatory bowel disease","volume":"99","author":"Goldstone","year":"2019","journal-title":"Surg Clin North Am."},{"key":"2022092518580893400_CIT0039","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/00365528009181475","article-title":"Endotoxin-induced microclots in ulcerative colitis and Crohn\u2019s disease","volume":"15","author":"Juhlin","year":"1980","journal-title":"Scand J Gastroenterol."},{"key":"2022092518580893400_CIT0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/gut.36.6.897","article-title":"Significance of systemic endotoxaemia in inflammatory bowel disease","volume":"36","author":"Gardiner","year":"1995","journal-title":"Gut."},{"key":"2022092518580893400_CIT0041","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med."},{"key":"2022092518580893400_CIT0042","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"2022092518580893400_CIT0043","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis","volume":"103","author":"Zwaka","year":"2001","journal-title":"Circulation."},{"key":"2022092518580893400_CIT0044","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet."},{"key":"2022092518580893400_CIT0045","doi-asserted-by":"crossref","first-page":"H1791","DOI":"10.1152\/ajpheart.00552.2003","article-title":"The vascular contribution in the pathogenesis of inflammatory bowel disease","volume":"285","author":"Hatoum","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"2022092518580893400_CIT0046","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","article-title":"Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?","volume":"46","author":"Van Doornum","year":"2002","journal-title":"Arthritis Rheum."},{"key":"2022092518580893400_CIT0047","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1194\/jlr.M700176-JLR200","article-title":"Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn\u2019s disease","volume":"48","author":"van Leuven","year":"2007","journal-title":"J Lipid Res."},{"key":"2022092518580893400_CIT0048","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cgh.2008.10.021","article-title":"Evidence of endothelial dysfunction in patients with inflammatory bowel disease","volume":"7","author":"Roifman","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092518580893400_CIT0049","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2036.2011.04864.x","article-title":"Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases","volume":"34","author":"Oussalah","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092518580893400_CIT0050","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1023\/A:1026338812708","article-title":"Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease","volume":"48","author":"Morgenstern","year":"2003","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0051","doi-asserted-by":"crossref","first-page":"e56944","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death\u2014a Danish nationwide cohort study","volume":"8","author":"Kristensen","year":"2013","journal-title":"PLoS One."},{"key":"2022092518580893400_CIT0052","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/BF02208650","article-title":"Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease","volume":"40","author":"Souto","year":"1995","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0053","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0016-5085(68)80041-1","article-title":"Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors","volume":"54","author":"Lee","year":"1968","journal-title":"Gastroenterology."},{"key":"2022092518580893400_CIT0054","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0016-5085(75)80005-9","article-title":"Coagulation studies in ulcerative colitis and Crohn\u2019s disease","volume":"68","author":"Lam","year":"1975","journal-title":"Gastroenterology."},{"key":"2022092518580893400_CIT0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/BF01536380","article-title":"Prothrombotic abnormalities in inflammatory bowel disease","volume":"34","author":"Conlan","year":"1989","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0056","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00001721-199212000-00011","article-title":"Evidence for activation of coagulation in Crohn\u2019s disease","volume":"3","author":"Hudson","year":"1992","journal-title":"Blood Coagul Fibrinolysis."},{"key":"2022092518580893400_CIT0057","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.33.4.502","article-title":"Circulating von Willebrand factor in inflammatory bowel disease","volume":"33","author":"Stevens","year":"1992","journal-title":"Gut."},{"key":"2022092518580893400_CIT0058","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF02064981","article-title":"Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases","volume":"40","author":"Sawyerr","year":"1995","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0059","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/00365529950173708","article-title":"Serum von Willebrand factor levels in patients with inflammatory bowel disease are related to systemic inflammation","volume":"34","author":"Meucci","year":"1999","journal-title":"Scand J Gastroenterol."},{"key":"2022092518580893400_CIT0060","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.3748\/wjg.v11.i48.7639","article-title":"Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation","volume":"11","author":"Zezos","year":"2005","journal-title":"World J Gastroenterol."},{"key":"2022092518580893400_CIT0061","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1097\/MIB.0000000000000531","article-title":"The occurrence of thrombosis in inflammatory bowel disease is reflected in the clot lysis profile","volume":"21","author":"Bollen","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2022092518580893400_CIT0062","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01732883","article-title":"Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis","volume":"61","author":"Jorens","year":"1990","journal-title":"Blut."},{"key":"2022092518580893400_CIT0063","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3109\/00365529209000170","article-title":"Free protein S deficiency in patients with chronic inflammatory bowel disease","volume":"27","author":"Aadland","year":"1992","journal-title":"Scand J Gastroenterol."},{"key":"2022092518580893400_CIT0064","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00365529409094844","article-title":"Free protein S deficiency in patients with Crohn\u2019s disease","volume":"29","author":"Aadland","year":"1994","journal-title":"Scand J Gastroenterol."},{"key":"2022092518580893400_CIT0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ajcp\/90.5.633","article-title":"Deep venous thrombosis, inflammatory bowel disease, and protein S deficiency","volume":"90","author":"Wyshock","year":"1988","journal-title":"Am J Clin Pathol."},{"key":"2022092518580893400_CIT0066","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/gut.30.2.188","article-title":"Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces","volume":"30","author":"de Jong","year":"1989","journal-title":"Gut."},{"key":"2022092518580893400_CIT0067","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00042737-200203000-00008","article-title":"Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease","volume":"14","author":"Hayat","year":"2002","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2022092518580893400_CIT0068","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0032-1305782","article-title":"Infection and inflammation as risk factors for thrombosis and atherosclerosis","volume":"38","author":"Levi","year":"2012","journal-title":"Semin Thromb Hemost."},{"key":"2022092518580893400_CIT0069","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1007\/s10620-015-3701-1","article-title":"Persistent reactive thrombocytosis may increase the risk of coronary artery disease among inflammatory bowel disease patients","volume":"60","author":"Thapa","year":"2015","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0070","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(94)90741-2","article-title":"Platelets circulate in an activated state in inflammatory bowel disease","volume":"106","author":"Collins","year":"1994","journal-title":"Gastroenterology."},{"key":"2022092518580893400_CIT0071","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2036.1997.153328000.x","article-title":"Review article: platelets in inflammatory bowel disease\u2014pathogenetic role and therapeutic implications","volume":"11","author":"Collins","year":"1997","journal-title":"Aliment Pharmacol Ther."},{"key":"2022092518580893400_CIT0072","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","article-title":"Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients","volume":"52","author":"Danese","year":"2003","journal-title":"Gut."},{"key":"2022092518580893400_CIT0073","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1542-3565(05)00154-0","article-title":"Thrombosis and inflammatory bowel disease","volume":"3","author":"Irving","year":"2005","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092518580893400_CIT0074","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000116773","article-title":"Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects","volume":"26","author":"Papa","year":"2008","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00001721-200203000-00005","article-title":"Cytokines in coagulation and thrombosis: a preclinical and clinical review","volume":"13","author":"Joseph","year":"2002","journal-title":"Blood Coagul Fibrinolysis."},{"key":"2022092518580893400_CIT0076","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MOG.0b013e32810c8de3","article-title":"Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow","volume":"23","author":"Danese","year":"2007","journal-title":"Curr Opin Gastroenterol."},{"key":"2022092518580893400_CIT0077","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/gut.36.5.724","article-title":"Adhesion molecules in inflammatory bowel disease","volume":"36","author":"Jones","year":"1995","journal-title":"Gut."},{"key":"2022092518580893400_CIT0078","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2249.1993.tb03455.x","article-title":"Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease","volume":"94","author":"Schuermann","year":"1993","journal-title":"Clin Exp Immunol."},{"key":"2022092518580893400_CIT0079","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","article-title":"Update on acute coronary syndromes: the pathologists\u2019 view","volume":"34","author":"Falk","year":"2013","journal-title":"Eur Heart J."},{"key":"2022092518580893400_CIT0080","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med."},{"key":"2022092518580893400_CIT0081","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart."},{"key":"2022092518580893400_CIT0082","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med."},{"key":"2022092518580893400_CIT0083","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cardiores.2004.07.006","article-title":"Does altered glucocorticoid homeostasis increase cardiovascular risk?","volume":"64","author":"Girod","year":"2004","journal-title":"Cardiovasc Res."},{"key":"2022092518580893400_CIT0084","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"Walker","year":"2007","journal-title":"Eur J Endocrinol."},{"key":"2022092518580893400_CIT0085","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jdiacomp.2018.05.015","article-title":"Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients","volume":"32","author":"Pepe","year":"2018","journal-title":"J Diabetes Complications."},{"key":"2022092518580893400_CIT0086","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.amjmed.2014.10.033","article-title":"Steroid exposure, acute coronary syndrome, and inflammatory bowel disease: insights into the inflammatory milieu","volume":"128","author":"Zakroysky","year":"2015","journal-title":"Am J Med."},{"key":"2022092518580893400_CIT0087","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J."},{"key":"2022092518580893400_CIT0088","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J."},{"key":"2022092518580893400_CIT0089","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ccd.27863","article-title":"Time-dependent benefits of pre-treatment with new oral P2Y12-inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction","volume":"93","author":"Pepe","year":"2019","journal-title":"Catheter Cardiovasc Interv."},{"key":"2022092518580893400_CIT0090","doi-asserted-by":"crossref","first-page":"e023337","DOI":"10.1136\/bmjopen-2018-023337","article-title":"Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review","volume":"9","author":"Ismail","year":"2019","journal-title":"BMJ Open."},{"key":"2022092518580893400_CIT0091","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1016\/j.crohns.2013.05.002","article-title":"Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center","volume":"7","author":"Tinsley","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2022092518580893400_CIT0092","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1155\/2012\/175249","article-title":"Survey of perceptions and practices among Canadian gastroenterologists regarding the prevention of venous thromboembolism for hospitalized inflammatory bowel disease patients","volume":"26","author":"Razik","year":"2012","journal-title":"Can J Gastroenterol."},{"key":"2022092518580893400_CIT0093","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10620-012-2435-6","article-title":"Physicians\u2019 perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease","volume":"58","author":"Sam","year":"2013","journal-title":"Dig Dis Sci."},{"key":"2022092518580893400_CIT0094","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MCG.0b013e31824c0dea","article-title":"A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States","volume":"47","author":"Tinsley","year":"2013","journal-title":"J Clin Gastroenterol."},{"key":"2022092518580893400_CIT0095","doi-asserted-by":"crossref","first-page":"134631","DOI":"10.5402\/2011\/134631","article-title":"Thrombotic occlusion of all left coronary branches in a young woman with severe ulcerative colitis","volume":"2011","author":"Gustavsson","year":"2011","journal-title":"ISRN Cardiol."},{"key":"2022092518580893400_CIT0096","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0003319717690993","article-title":"Inflammatory bowel disease: a potential risk factor for coronary artery disease","volume":"68","author":"Tsigkas","year":"2017","journal-title":"Angiology."},{"key":"2022092518580893400_CIT0097","first-page":"876896","article-title":"Acute myocardial infarction complicating active ulcerative colitis: a case report","volume":"2011","author":"Papadimitraki","year":"2011","journal-title":"Case Rep Cardiol."},{"key":"2022092518580893400_CIT0098","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/echo.13081","article-title":"Left ventricular thrombus in the setting of normal left ventricular function in patients with Crohn\u2019s disease","volume":"33","author":"Rasalingam","year":"2016","journal-title":"Echocardiography."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/5\/725\/46040775\/izaa160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/5\/725\/46040775\/izaa160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T19:00:06Z","timestamp":1664132406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/27\/5\/725\/5863988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":98,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,6,27]]},"published-print":{"date-parts":[[2021,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa160","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,6,27]]}}}